Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study

View ORCID ProfileSharon Walmsley, Leah Szadkowski, Bradly Wouters, Rosemarie Clarke, Karen Colwill, Paula Rochon, Michael Brudno, Rizani Ravindran, Janet Raboud, Allison McGeer, Amit Oza, Christopher Graham, Amanda Silva, Dorin Manase, Laura Parente, Jacqueline Simpson, Roaya Monica Dayam, Adrian Pasculescu, Anne-Claude Gingras
doi: https://doi.org/10.1101/2022.02.09.22270734
Sharon Walmsley
1Department of Medicine, University Health Network, University of Toronto, 13EN-Room 214, 200 Elizabeth Street, Toronto, Ontario, Canada
CM, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sharon Walmsley
  • For correspondence: Sharon.walmsley{at}uhn.on.ca
Leah Szadkowski
2Department of Biostatistics, University Health Network, University of Toronto, Toronto< Ontario, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradly Wouters
3University Health Network, PMCC, University of Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosemarie Clarke
4University Health Network, Immunodeficiency clinic, University of Toronto, Toronto, Ontario, Canada
RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Colwill
5Staff Scientist, Network Biology Collaborative Centre Manager, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula Rochon
6Women’s College Research Institute, Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Brudno
7University of Toronto, Department of Computer Science, University of Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rizani Ravindran
8University Health Network, Toronto General Hospital Research Institute, University of Toronto, Toronto, Ontario, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet Raboud
9Emeritus Scientist, Toronto General Hospital Research Institute, University of Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison McGeer
10Mount Sinai Hospital, Department of Infection Control, University of Toronto, Toronto, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit Oza
11University Health Network, Princess Margaret Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Graham
10Mount Sinai Hospital, Department of Infection Control, University of Toronto, Toronto, Ontario, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Silva
11University Health Network, Princess Margaret Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorin Manase
11University Health Network, Princess Margaret Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Parente
11University Health Network, Princess Margaret Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline Simpson
12Trillium Health Partners, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roaya Monica Dayam
13Department of BioInformatics, University Health Network, University of Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Pasculescu
13Department of BioInformatics, University Health Network, University of Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Claude Gingras
13Department of BioInformatics, University Health Network, University of Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background To partially immunize more persons against COVID-19 during a time of limited vaccine availability, Canadian public health officials recommended extending the vaccine dose interval and brand mixing. Impact on the antibody response among the older ambulatory population was unclear.

Methods Decentralized prospective cohort study with self-report of adverse events and collection of dried blood spots. Data is presented for 1193 (93%) of the 911 older (aged >70 years) and 375 younger (30-50 years) recruits.

Findings Local and systemic reactivity rates were high but short-lived, particularly in the younger cohort and with mRNA-1273 vaccine. After a single COVID-19 vaccine, 84% younger but only 46% older participants had positive IgG antibodies to both spike protein and receptor binding domain (RBD) antigens, increasing to 100/98% with the second dose respectively. In multivariable linear regression model, lower normalized IgG RBD antibody ratios two weeks after the second dose were statistically associated with older age, male gender, cancer diagnosis, lower body weight, BNT162b2 relative to mRNA-1273 and longer dose intervals. Antibody ratios in both cohorts declined 12 weeks post second vaccine dose.

Interpretation We report success of a decentralized serology study. Antibody responses were higher in the younger than older cohort and were greater for those with at least one mRNA-1273 dose. The immunity threshold is unknown but correlations between binding and neutralizing antibodies are strongly positive. Trends with time and at breakthrough infection will inform vaccine booster strategies.

Funding Supported by the Public Health Agency of Canada and the University Health Network Foundation.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT05208983

Funding Statement

This study was funded by the Public Health Agency of Canada and the University Health Network Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics review committee of the university health network, Toronto, gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 10, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study
Sharon Walmsley, Leah Szadkowski, Bradly Wouters, Rosemarie Clarke, Karen Colwill, Paula Rochon, Michael Brudno, Rizani Ravindran, Janet Raboud, Allison McGeer, Amit Oza, Christopher Graham, Amanda Silva, Dorin Manase, Laura Parente, Jacqueline Simpson, Roaya Monica Dayam, Adrian Pasculescu, Anne-Claude Gingras
medRxiv 2022.02.09.22270734; doi: https://doi.org/10.1101/2022.02.09.22270734
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study
Sharon Walmsley, Leah Szadkowski, Bradly Wouters, Rosemarie Clarke, Karen Colwill, Paula Rochon, Michael Brudno, Rizani Ravindran, Janet Raboud, Allison McGeer, Amit Oza, Christopher Graham, Amanda Silva, Dorin Manase, Laura Parente, Jacqueline Simpson, Roaya Monica Dayam, Adrian Pasculescu, Anne-Claude Gingras
medRxiv 2022.02.09.22270734; doi: https://doi.org/10.1101/2022.02.09.22270734

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3296)
  • Dentistry and Oral Medicine (364)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13381)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5155)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3271)
  • Health Policy (1142)
  • Health Systems and Quality Improvement (1192)
  • Hematology (431)
  • HIV/AIDS (1018)
  • Infectious Diseases (except HIV/AIDS) (14632)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4928)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (726)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4216)
  • Public and Global Health (7506)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1014)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)